ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,988Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 223

$742K Total Retail Price of All Prescriptions

Rank: 20 out of 223

482 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 482 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 482 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 10,340 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
SIMVASTATIN 579 525 1 1
OMEPRAZOLE 489 422 2 3
LEVOTHYROXINE SODIUM 482 445 3 2
LISINOPRIL 434 395 4 4
ZOLPIDEM TARTRATE 281 265 5 8
FUROSEMIDE 269 254 6 9
AMLODIPINE BESYLATE 259 238 7 6
HYDROCODONE-ACETAMINOPHEN 258 230 S3 8 5
GABAPENTIN 218 181 9 10
HYDROCHLOROTHIAZIDE 182 175 10 13
METOPROLOL SUCCINATE 179 168 11 20
ALENDRONATE SODIUM 171 134 12 19
POTASSIUM CHLORIDE 170 166 13 12
METFORMIN HCL 168 131 14 7
ATORVASTATIN CALCIUM 167 154 15 17
METOPROLOL TARTRATE 159 152 16 25
CITALOPRAM HBR 155 146 17 16
LOSARTAN POTASSIUM 150 129 18 14
TAMSULOSIN HCL 141 131 19 26
PRAVASTATIN SODIUM 140 107 20 15
WARFARIN SODIUM 139 136 21 11
CARVEDILOL 133 126 22 23
LYRICA 115 99 23 84
VENLAFAXINE HCL ER 115 91 23 83
GLIMEPIRIDE 107 98 25 30
TRAMADOL HCL 107 104 25 18
SERTRALINE HCL 106 102 27 21
PAROXETINE HCL 103 91 28 52
DONEPEZIL HCL 103 103 28 36
HYDROXYCHLOROQUINE SULFATE 98 87 30 108
OXYBUTYNIN CHLORIDE 95 91 31 75
NAMENDA 95 83 31 48
ROPINIROLE HCL 95 79 31 62
LANTUS 93 65 34 34
ESTRADIOL 88 69 R 35 59
ALLOPURINOL 87 75 36 28
KLOR-CON 10 81 79 37 158
ATENOLOL 72 68 38 32
BENAZEPRIL HCL 70 55 39 57
FLUTICASONE PROPIONATE 68 63 40 27
ENDOCET 67 54 S2 41 133
OXYBUTYNIN CHLORIDE ER 66 65 42 109
MELOXICAM 65 65 43 33
KLOR-CON M10 60 58 44 141
DIOVAN 59 59 45 54
AMITRIPTYLINE HCL 58 54 R 46 61
PANTOPRAZOLE SODIUM 58 58 46 45
QUETIAPINE FUMARATE 57 36 48 70
PREDNISONE 56 46 49 43
SYNTHROID 54 41 50 35
MORPHINE SULFATE ER 53 42 S2 51 90
ISOSORBIDE MONONITRATE ER 53 43 51 110
CLOPIDOGREL 52 44 53 56
FENTANYL 52 31 S2 53 91
PREMARIN 51 50 R 55 115
NIASPAN 50 31 56 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.